𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of Phantom Limb Pain with Botulinum Toxin Type A

✍ Scribed by Katja Kollewe; Lingjing Jin; Klaus Krampfl; Reinhard Dengler; Bahram Mohammadi


Book ID
109104009
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
112 KB
Volume
10
Category
Article
ISSN
1526-2375

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Botulinum toxin type a for painful limbs
✍ Andreas A. Argyriou; Spyridon Papapetropoulos πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

Lerner and Bagic 1 have to be congratulated for their hypothesis on PD pathogenesis. They suggest that the sequence of the brain changes in PD follows specific and repeatable patterns in all cases, as well as that a prion-like process underlies neurodegeneration. These ideas could explain several fe

Frey syndrome : Treatment with type A bo
✍ Jens J. von Lindern; Bernd Niederhagen; Stefan BergΓ©; Georg HΓ€gler; Rudolf H. Re πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 448 KB πŸ‘ 1 views

## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li

Effectiveness of botulinum toxin type A
✍ Kathleen B. Polo; Dr. Bahman Jabbari πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

## Abstract Botulinum toxin is now an established treatment for blepharospasm, hemifacial spasm, spasmodic torticollis, and spastic dysphonia. We report the effectiveness of botulinum toxin against painful limb myoclonus of spinal cord origin. The patient, a 16‐year‐old girl with a pulmonary vascul

Botulinum toxin type A for the treatment
✍ Claus Wittekindt Vasan; Wei-Chi Liu; Jens-Peter Klussmann; Orlando Guntinas-Lich πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

## Abstract ## Background. Neck dissection surgery is often followed by chronic head and neck pain. To date optimal treatment of this type of pain is lacking. Botulinum toxin type A (BTX‐A) has been shown to be effective in the treatment of myofascial pain syndrome and headache. In a pilot study,